Graypoint LLC Raises Position in Aflac Incorporated (NYSE:AFL)

Graypoint LLC raised its stake in shares of Aflac Incorporated (NYSE:AFL) by 15.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,854 shares of the financial services provider’s stock after purchasing an additional 795 shares during the period. Graypoint LLC’s holdings in Aflac were worth $483,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Baystate Wealth Management LLC raised its position in Aflac by 24.1% during the third quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider’s stock valued at $52,000 after purchasing an additional 131 shares during the period. Dominguez Wealth Management Solutions Inc. raised its holdings in shares of Aflac by 0.5% in the third quarter. Dominguez Wealth Management Solutions Inc. now owns 24,969 shares of the financial services provider’s stock worth $1,916,000 after buying an additional 132 shares during the period. Brighton Jones LLC raised its holdings in shares of Aflac by 2.3% in the third quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider’s stock worth $472,000 after buying an additional 136 shares during the period. MV Capital Management Inc. raised its holdings in shares of Aflac by 3.7% in the third quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider’s stock worth $290,000 after buying an additional 136 shares during the period. Finally, Simon Quick Advisors LLC raised its holdings in shares of Aflac by 4.9% in the fourth quarter. Simon Quick Advisors LLC now owns 2,950 shares of the financial services provider’s stock worth $243,000 after buying an additional 139 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AFL has been the topic of several recent analyst reports. Evercore ISI downgraded Aflac from an “in-line” rating to an “underperform” rating and increased their price target for the stock from $76.00 to $78.00 in a report on Thursday, January 4th. Keefe, Bruyette & Woods increased their price target on Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a report on Wednesday, April 10th. UBS Group increased their price objective on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 10th. Wells Fargo & Company dropped their price objective on Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a research note on Thursday. Finally, StockNews.com cut Aflac from a “hold” rating to a “sell” rating in a research note on Wednesday, April 10th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to MarketBeat, Aflac has an average rating of “Hold” and an average target price of $81.85.

Aflac Stock Up 0.8 %

Shares of NYSE AFL opened at $80.28 on Monday. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $46.19 billion, a PE ratio of 10.36, a price-to-earnings-growth ratio of 2.19 and a beta of 0.91. The stock’s fifty day simple moving average is $81.88 and its two-hundred day simple moving average is $81.42. Aflac Incorporated has a 12-month low of $64.10 and a 12-month high of $86.26.

Aflac (NYSE:AFL) last announced its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.47 by ($0.22). The company had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same period last year, the business posted $1.29 EPS. As a group, analysts expect that Aflac Incorporated will post 6.41 EPS for the current fiscal year.

Insider Transactions at Aflac

In other news, Director Masatoshi Koide sold 30,493 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the sale, the director now owns 86,090 shares of the company’s stock, valued at approximately $6,879,451.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Masatoshi Koide sold 30,493 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the sale, the director now owns 86,090 shares of the company’s stock, valued at approximately $6,879,451.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Albert Riggieri sold 8,000 shares of the firm’s stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the transaction, the senior vice president now owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The disclosure for this sale can be found here. Insiders sold 46,493 shares of company stock valued at $3,765,706 in the last quarter. 0.90% of the stock is currently owned by corporate insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.